Ingalls & Snyder LLC’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $336K | Sell |
|
|||||
|
2025
Q1 | $337K | Sell |
|
|||||
|
2024
Q4 | $394K | Sell |
|
|||||
|
2024
Q3 | $491K | Hold |
|
|||||
|
2024
Q2 | $461K | Sell |
|
|||||
|
2024
Q1 | $477K | Sell |
|
|||||
|
2023
Q4 | $458K | Sell |
|
|||||
|
2023
Q3 | $435K | Sell |
|
|||||
|
2023
Q2 | $542K | Sell |
|
|||||
|
2023
Q1 | $499K | Sell |
|
|||||
|
2022
Q4 | $585K | Sell |
|
|||||
|
2022
Q3 | $801K | Sell |
|
|||||
|
2022
Q2 | $755K | Sell |
|
|||||
|
2022
Q1 | $978K | Sell |
|
|||||
|
2021
Q4 | $1.48M | Sell |
|
|||||
|
2021
Q3 | $1.67M | Sell |
|
|||||
|
2021
Q2 | $1.86M | Sell |
|
|||||
|
2021
Q1 | $2.1M | Sell |
|
|||||
|
2020
Q4 | $2.19M | Sell |
|
|||||
|
2020
Q3 | $1.95M | Buy |
|
|||||
|
2020
Q2 | $280K | Buy |
|